NEW DELHI : Serum Institute of India (SII), the local maker of the AstraZeneca/Oxford coronavirus vaccine, said on Sunday it intends to concentrate on meeting India's own immediate demand in the next two months before exporting to other interested countries.
Chief Executive Adar Poonawalla said in an interview after the shot was approved for emergency use in the world's second-most populous country, that exports might be possible after supplying the Indian government with an initial 100 million doses.
The Indian government just wants to ensure that "the most vulnerable people of the country get it first - I fully endorse and support that decision", he said.
SII is still waiting to strike a formal supply deal with the Indian government, but is expected to do so in the coming days.
Chief Executive Adar Poonawalla said in an interview after the shot was approved for emergency use in the world's second-most populous country, that exports might be possible after supplying the Indian government with an initial 100 million doses.
The Indian government just wants to ensure that "the most vulnerable people of the country get it first - I fully endorse and support that decision", he said.
SII is still waiting to strike a formal supply deal with the Indian government, but is expected to do so in the coming days.
Read More News on
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Also Read
4 Comments on this Story
 | Shah 16 minutes ago i sincerely urge the moderator ti delete the nonsensical and false opinionated comment by shubharaj sain. He has no right to defame such a reputed and dignified organization who is trying its best in such trafic times to serve humanity. such useless readers and comments are unwarranted here. |
| ekta25 minutes ago you fool shubharaj sain |
| SHUBHARAJ SAIN1 hour ago Poonawala will now earn billions by selling its fake vaccine...made without proper tests... |